Alzheimer's, Parkinson's, Type 2 Diabetes Similar At Molecular Level

Main Category: Biology / Biochemistry
Also Included In: Alzheimer's / Dementia;  Parkinson's Disease;  Diabetes
Article Date: 04 May 2007 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.4 (5 votes)

Healthcare Prof:5 stars

5 (1 votes)


Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature.

While still preliminary, the research, could help scientists develop tools for diagnosing such diseases, and potentially for treating them through "structure-based drug design," said David Eisenberg, a UCLA chemist and molecular biologist who is part of the research team.

The researchers studied the harmful rope-like structures known as amyloid fibrils--linked protein molecules that form in the brain. The fibrils contain a stack of water-tight "molecular zippers."

"With each disease, a different protein transforms into amyloid fibrils, but all of these diseases are similar at the molecular level," Eisenberg said.

If the molecular zipper is universal in amyloid fibrils, as Eisenberg believes, is it possible to pry open the zipper or prevent its formation?

Eisenberg's research team used X-ray analysis and a sophisticated computer algorithm to study proteins known to be associated with human diseases. When the computer said a protein will form an amyloid fibril, it almost always did. And one team member is experimenting with various compounds to break up the fibrils.

"Structural analysis of micro-crystals of proteins is an example of how basic research can have a profound impact on our understanding of health, biotechnology and other practical issues," said Parag Chitnis, program director in National Science Foundation's (NSF) Division of Molecular and Cellular Biosciences.

###

NSF, the Howard Hughes Medical Institute and the National Institutes of Health supported the research.

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering, with an annual budget of $5.58 billion. NSF funds reach all 50 states through grants to nearly 1,700 universities and institutions. Each year, NSF receives about 40,000 competitive requests for funding, and makes nearly 10,000 new funding awards. The NSF also awards over $400 million in professional and service contracts yearly.

Useful NSF Web Sites:

NSF Home Page: http://www.nsf.gov/

NSF News: http://www.nsf.gov/news/

Science and Engineering Statistics: http://www.nsf.gov/statistics/

Awards Searches: http://www.nsf.gov/awardsearch/

Contact: Cheryl Dybas
National Science Foundation

Article adapted by Medical News Today from original press release.
Visit our biology / biochemistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cheryl Dybas. "Alzheimer's, Parkinson's, Type 2 Diabetes Similar At Molecular Level." Medical News Today. MediLexicon, Intl., 4 May. 2007. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/69488.php>

APA
Cheryl Dybas. (2007, May 4). "Alzheimer's, Parkinson's, Type 2 Diabetes Similar At Molecular Level." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/69488.php.

Please note: If no author information is provided, the source is cited instead.


Biology / Biochemistry

Most Popular Articles



Follow Our Biology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Biology / Biochemistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »